As radiopharmaceuticals enter a new phase, industry leaders must rethink external services and internal capabilities to master the complexities of delivering advanced therapies. The post Unlocking the Future of Radioligand Therapy: From Discovery to Delivering at Scale appeared first on MedCity News.
Jason Farned y su equipo en el Distrito de Control de Mosquitos y Vectores del Valle de San Gabriel habían pasado años preparándose para la posible llegada del dengue, un virus peligroso que normalmente se encuentra en climas tropicales fuera de Estados Unidos continental. Habían observado con nerviosismo cómo las especies de mosquitos Aedes invasores,…
According to Experian Health’s State of Claims 2024 survey, missing coverage is the top reason for healthcare claim denials for almost a fifth of providers. However, the issue isn’t just about whether a patient is insured — four in ten providers worry about insurance companies paying out even where patients have active coverage. Constantly changing…
Jason Farned and his team at the San Gabriel Valley Mosquito and Vector Control District had spent years preparing for the likely arrival of dengue, a dangerous virus typically found in tropical climates outside the mainland United States. They’d watched nervously as invasive Aedes mosquito species that can carry the virus appeared in Los Angeles…
Donald Hammen, 80, and his longtime next-door neighbor in south Minneapolis, Julie McMahon, have an understanding. Every morning, she checks to see whether he’s raised the blinds in his dining room window. If not, she’ll call Hammen or let herself into his house to see what’s going on. Should McMahon find Hammen in a bad…
By MICHAEL MILLENSON Open enrollment season for Medicare, which began Oct. 15 and ends Dec. 7, triggers a deluge of information about various options. Since I’m a health care consultant and researcher as well as a Medicare beneficiary, I’ve looked critically at what we’re told and what we’re not. Unfortunately, information crucial both for the…
During a recent panel, experts discussed the Massachusetts Child Psychiatry Access Program (MCPAP) for Moms and how it achieved scale. The post How One Massachusetts Maternal Mental Health Program Scaled Across the Country appeared first on MedCity News.
Here’s how four different health systems are partnering with Microsoft to save time for clinicians. The post How 4 Health Systems Are Partnering with Microsoft appeared first on MedCity News.
That is the title of a new publication with co-authors Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke. This consensus paper aims to provide researchers with a user guide for estimating broader societal value…
AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb’s Cobenfy, is from AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics. The post AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test appeared first on…